Literature DB >> 10926795

Intratumoral genetic heterogeneity and progression of endometrioid type endometrial adenocarcinomas.

W C Faquin1, J T Fitzgerald, K A Boynton, G L Mutter.   

Abstract

OBJECTIVES: Development of genetic heterogeneity is one mechanism whereby tumors may acquire increasing aggressiveness during neoplastic progression. In this study we relate development of intratumoral genetic heterogeneity to invasion and metastatic spread of sporadic endometrioid (type I) endometrial adenocarcinomas.
METHODS: Microsatellite unstable adenocarcinomas underwent detailed microsatellite allelotype mapping with reconstruction of neoplastic lineages using maximum parsimony analysis.
RESULTS: Within individual patients, tumor allelotypes sometimes varied between regions of histologically identical tumor, indicating that genotypic variation may reflect differences inapparent by histology. Comparison of noninvasive (surface/luminal) with invasive (myometrial invasion or metastasis) carcinoma showed highly related genotypes in 3/8 cases in which the invasive component can be recognized as evolved from the superficial tumor lineage by progressive clonal selection. In 3/8 cases superficial and invasive genotypes independently evolved different sets of altered microsatellites, indicating either divergence at an early stage in tumor evolution or independent selection events. A total of 2/8 cases had random patterns of marker distribution between sampled areas that were not informative in delineating systematic relationships between surface and invasive tumor.
CONCLUSIONS: We conclude from these results that endometrial tumor progression may occur through physical extension of existing clones or through creation of new subclones with altered growth properties. The latter occurs in about half of cases, where myometrial invasion may select for particular clones that are poorly represented on the luminal surface. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926795     DOI: 10.1006/gyno.2000.5858

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.

Authors:  George L Mutter; Nicolas M Monte; Donna Neuberg; Alex Ferenczy; Charis Eng
Journal:  Cancer Res       Date:  2014-03-24       Impact factor: 12.701

2.  Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study.

Authors:  George L Mutter; James Kauderer; Jan P A Baak; David Alberts
Journal:  Hum Pathol       Date:  2008-04-23       Impact factor: 3.466

3.  Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Diagn Pathol       Date:  2008-02-08       Impact factor: 2.644

4.  Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.

Authors:  Rain R Chen; Mingo M H Yung; Yang Xuan; Shijie Zhan; Leanne L Leung; Rachel R Liang; Thomas H Y Leung; Huijuan Yang; Dakang Xu; Rakesh Sharma; Karen K L Chan; Siew-Fei Ngu; Hextan Y S Ngan; David W Chan
Journal:  Commun Biol       Date:  2019-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.